Today's Date: June 3, 2023
Navidea Biopharmaceuticals, Inc. Receives NYSE American Notice   •   Bijou Ikli named new CEO by Florida Assisted Living Association   •   INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of DZS Inc. (DZSI) on Behalf of Investors   •   UNice Celebrates LGBTQ Pride Month   •   INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of SentinelOne, Inc. (S) on Behalf of Investors   •   56 Trilogy Health Services Communities Earn 2023 AHCA/NCAL Bronze National Quality Award   •   San Francisco Pride Announces Headliners Hayley Kiyoko and Princess Nokia for 53rd Annual SF Pride Parade & Celebration Feat   •   Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of LivePerson, Inc. (LPSN) Investors   •   HESAI DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Hesai   •   BURGERFI DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Bu   •   SENTINELONE ALERT: Bragar Eagel & Squire, P.C. is Investigating SentinelOne, Inc. on Behalf of SentinelOne Stockholders and   •   Statement from Minister Hutchings on progress in support of rural Canadians   •   Hilton brings back exclusive pop-up hotel experience 'Hilton on the Green' to the 2023 RBC Canadian Open   •   Rapid Dose Announces Proposed Private Placement Financing   •   ETHNIC CONFLICTS IN NIGERIA: UNMASKING THE PUPPET MASTERS   •   SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Funko, Inc. with Losses of $100,000 to Contact the Firm   •   FNKO INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Funko, Inc. Investors with Substantial Losses Have Opp   •   CURE HOSTS "AI FOR GOOD" SUPER SESSION TO MAKE SENSE OF BIG DATA AND HIGH TECH AT 2023 BIO INTERNATIONAL CONVENTION ON JUNE 5   •   The Assembly of First Nations and the Government of Canada announce updates to school design standards for schools on-reserve   •   Promoting Diversity and Equity in Cancer Research, Women Leaders in Oncology® and Vaniam Group Announce Recipients of 2023 Y
Bookmark and Share

Mispro Biotech Services Celebrates 20th Anniversary with a Fresh Look: Company Unveils Brand Refresh to Mark Two Decades of Inno

CAMBRIDGE, Mass. , March 21 /Businesswire/ - Mispro Biotech Services, North America's pioneering contract vivarium organization (CVO), is proud to announce its 20th anniversary and brand refresh to commemorate the occasion.

Since its founding in 2003, Mispro has established itself as a trusted partner for biotech and biopharma companies seeking high-quality laboratory animal research facilities and services. As the company marks its 20th year in business, the brand refresh aims to reflect the company's evolution while embodying its forward-thinking approach and dedication to growth.

With an established brand and reputation as a market leader, Mispro has opted for a distinct brand refresh rather than a drastic overhaul. The new branding features a clean, modern logo that retains the company's signature blue colors and streamlines the company's trade name to the concise, and familiar, "Mispro."

"We are thrilled to celebrate our 20th year and are committed to continuing our growth in existing and new markets," said Mispro CEO Philippe Lamarre. "Our brand refresh reflects our singular focus on providing the most effective, sensible, and ethical research environments for scalable preclinical drug development studies in the market. This is an exciting step for Mispro as we continue to look towards the future."

Mispro's new branding will be reflected in advertising, online, in its facilities, and at events celebrating the company's 20th anniversary.

To learn more about Mispro's brand refresh and logo, visit Mispro 2023 Rebrand or follow Mispro on Twitter and LinkedIn.

About Mispro

Mispro is an AAALAC-accredited contract vivarium organization (CVO) offering a network of full-service vivarium lab facilities for preclinical in vivo rodent studies. Along with access to state-of-the-art lab spaces, Mispro supports its clients with comprehensive laboratory animal research services, including husbandry, veterinary, technical, and regulatory compliance oversight. With locations in all major U.S. biotech hubs, Mispro is committed to helping biosciences companies of all sizes and therapeutic indications achieve their research goals.

STORY TAGS: United States, North America, Biotechnology, Health, Science, Pharmaceutical, Research, Massachusetts, Company Name Change,


White House Live Stream
Breaking News
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News